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Abstract
Background: The planning and assessment of malaria interventions is complicated due to fluctuations in the
burden of malaria over time. Recently, it has been reported that the burden of malaria in some parts of Africa has
declined. However, community-based longitudinal data are sparse and the reasons for the apparent decline are not
well understood.
Methods: Malaria prevalence and morbidity have been monitored in two villages in north-eastern Tanzania; a
lowland village and a highland village from 2003 to 2008. Trained village health workers treated presumptive
malaria with the Tanzanian first-line anti-malarial drug and collected blood smears that were examined later. The
prevalence of malaria parasitaemia across years was monitored through cross-sectional surveys.
Results: The prevalence of malaria parasitaemia in the lowland village decreased from 78.4% in 2003 to 13.0% in
2008, whereas in the highland village, the prevalence of parasitaemia dropped from 24.7% to 3.1% in the same
period. Similarly, the incidence of febrile malaria episodes in the two villages dropped by almost 85% during the
same period and there was a marked reduction in the number of young children who suffered from anaemia in
the lowland village.
Conclusion: There has been a marked decline in malaria in the study villages during the past few years. This
decline is likely to be due to a combination of factors that include improved access to malaria treatment provided
by the trained village helpers, protection from mosquitoes by increased availability of insecticide-impregnated bed
nets and a reduced vector density. If this decline in malaria morbidity is sustained, it will have a marked effect on
the disease burden in this part of Tanzania.
Background
There have been previous efforts to eradicate or, if this
was not possible, to eliminate malaria, but these ambi-
tious goals have not been achieved in large parts of
Africa [1-5] despite the development of effective tools,
such as insecticide-impregnated bed nets (ITNs) and
case management on demand; and malaria vaccines are
being developed to complement the existing tools [6-9].
The performance of these tools can be monitored by
careful surveillance of the malaria burden in a defined
community before and after their deployment [10-12].
However, malaria transmission and the associated
disease burden can fluctuate in the absence of any
intervention due to climatic variations and societal
behavioural changes. These changes can be dramatic in
areas of unstable and seasonal malaria transmission, but
are much less pronounced in areas of high and stable
transmission [13,14]. In the past few years, reports have
documented that the malaria burden has diminished in
several areas of Africa [15-18], but the reasons for these
changes are still uncertain. This fortunate development
has been ascribed to a combination of interventions,
such as use of ITNs, artemisinin combination therapy
(ACT) and indoor residual spraying (IRS) [16]. This
paper documents a marked decline in the malaria bur-
d e ni nt w oT a n z a n i a nv i l l a g e si na na r e aw i t hs t a b l e
malaria transmission during the period 2003 to 2008.
The decrease was most marked in a village where trans-
mission was high at the beginning of the study and took
place before the introduction of ACT.
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Study area
The study was conducted in Korogwe District, north-
eastern Tanzania. Korogwe District is about 100 kilo-
meters inland from the coastal town, Tanga. It is a tro-
pical area with two rainy seasons: April to June and
October to December. January and February are nor-
mally dry, but recently there have been climatic changes
with merging of these two rainy seasons. Entomological
surveys in the study area have shown that Anopheles
gambiae is the most prevalent vector in the lowlands,
while Anopheles funestus predominates in the highlands.
In previous studies, entomological inoculation rates
(EIR) have been reported to be more than 100 in the
lowlands, but less than 30 infective bites per person per
year at intermediate altitudes. In the highlands, mos-
quito densities are too low to allow reliable EIR mea-
surements, but an EIR of 0.03 infective bites per person
per year has been extrapolated [19]. There is no recent
entomology data for the area, the most recent were col-
lected in the late 1990 s. Plasmodium falciparum is the
dominant malaria parasite with Plasmodium malariae
being encountered occasionally. Villagers perceive
malaria as a major health problem among both children
and adults leading to disease and deaths.
The study was conducted in two villages, Mkokola and
Kwamasimba, which had 2,000 and 1,800 inhabitants,
respectively in 2003. Mkokola village is situated at an
altitude of about 300 meters above sea level (lowland
village) and Kwamasimba at an altitude of approximately
700 meters (highland village). The two villages are
approximately 15 kilometres apart [20-22].
Longitudinal detection of febrile episodes
In January 2003, management of uncomplicated malaria
cases by trained village health workers was introduced
into the study villages. The village health workers,
locally called Community Owned Resource Persons
(CORPS) carried out passive case detection of subjects
with fever. There were two CORPS in each village, one
of whom was always present in the village, so that any
village resident who had a febrile illness, had an oppor-
tunity to obtain treatment at any time. The CORPS
were provided with thermometer, first-line anti-malarial
drugs (sulphadoxine-pyrimethamine [SP] up to 2006
and artemether-lumefantrine [ALu] from 2007 to date),
paracetamol, slides, blood lancets, gloves, treatment
charts, febrile case detection forms and storage boxes.
CORPS were instructed how to collect blood smears
under aseptic technique and to preserve these until col-
lected by a team of supervisors composed of a clinical
o f f i c e ra n dal a b o r a t o r yt e c h n i c i a n .C O R P Sw e r ea l s o
instructed on how to treat patients with the first-line
anti-malarial drug and an antipyretic, and how to refer
patients who had severe symptoms or who did not
respond adequately to the first-line anti-malarial treat-
ment to Korogwe District Hospital. Villagers were
informed that they could call on the CORPS at any time
if they had symptoms of malaria. From suspected
malaria cases, the CORPS would then collect basic clini-
cal data, obtain a blood smear for malaria microscopy
and institute presumptive malaria treatment. Patients
with severe symptoms or symptoms suggestive of other
diseases than malaria were referred to the local dispen-
sary or the District Hospital.
Cross-sectional surveys
Malaria cross-sectional surveys were conducted in the
two study villages from 2003 to 2008 (Table 1). The sur-
veys were conducted in May during the main rainy sea-
son in the years 2003-2008, and just before the short
rains in November in the years 2003-2007. During each
cross-sectional survey, demographic data were collected
together with a history of migration and recent travel.
The reported use of a bed net was also recorded. A his-
tory of recent illness was obtained, emphasizing symp-
toms suggestive of malaria. Physical examination for
signs related to malaria, such as temperature, pulse,
spleen size, pallor or a raised respiratory rate was con-
ducted. Axillary temperature was measured using digital
thermometers. For any individual diagnosed with a mild
disease, appropriate drugs were administered.
Five millilitres of venous blood were collected from
individuals aged three years or more. For children below
three years, 300-400 μl of capillary blood was obtained
by finger prick into an Eppendorf tube containing
EDTA. The haemoglobin (Hb) concentration of each
participant was measured using a HemoCue® photo-
meter (Ångelholm, Sweden). Whole blood was used to
prepare thick and thin blood smears for malaria micro-
scopy. These were stained with 10% Giemsa stain for
15-20 minutes after fixing thin smears with methanol.
Asexual and sexual parasites were counted against 200
and 500 white blood cells, respectively. The differentia-
tion of malaria parasite species was confirmed by micro-
scopy of thin smears. A blood smear was declared
negative only after examination of 200 high power fields.
The density of asexual parasites was calculated assuming
8,000 leucocytes per μl of blood and expressed as para-
sites per μl. Slides were red retrospectively and during
surveys malaria treatment was only given to patients
complaining of malaria symptoms.
Data management and analysis
All data were double-entered into a Microsoft Access
database, cleaned, validate da n dt r a n s f e r r e di n t oS t a t a
version 9 (Stata Corporation, Texas, USA) and R 2.7.0
for statistical analysis. Fever was defined as an observed
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within the previous 24 hours. A febrile malaria episode
was defined as an episode of fever with a positive blood
smear for asexual Plasmodium falciparum parasitaemia
of any density. The summary measures consisted of per-
centage for categorical variables and means for continu-
ous variables. Incidence was calculated as documented
number of febrile malaria episodes to the population
size in each age group and/or village per year.
In modelling the risk of Plasmodium falciparum, para-
siteamia across the years, number of individuals with
parasitaemia during cross-sectional surveys were mod-
elled as a binomial random variable using logistic
regression. The model was fitted for each village sepa-
rately and was adjusted for the effect of age and use of
bednets. To compare the risk of Plasmodium falciparum
infection between the two villages, a similar model was
fitted for the two villages. In addition, linear regression
models were used to determine the changes in mean
haemoglobin (Hb) concentration across years and effect
of Plasmodium falciparum parasiteamia and season on
Hb levels while controlling for age and reported use of
insecticide-treated or non-treated bed nets. In this
model the effect of year was fitted as a categorical vari-
able. A statistical significance level was considered at
P-value < 0.05.
Ethical considerations
Ethical clearance was granted by the Medical Research
Co-ordinating Committee of the National Institute for
Medical Research, Tanzania. Prior to the study,
meetings were held with local authorities and with the
villagers in each study village, during which the aims of
the study were explained. Informed consent documents
for the study were prepared in English and translated
into Kiswahili before administration to both village lea-
ders and participants. Written informed consent to par-
ticipate was obtained from each study individual or
from his or her parent or guardian. Villagers were free
not to participate in the study without giving any rea-
sons, or being disqualified from any medical services
that were provided to all villagers throughout the study
period. Feedback to the village has been performed
continuously during the study.
Results
Malaria parasitaemia by year
At the first cross-sectional survey, P. falciparum was
detected in 78% and 25% of the residents of lowland
and highland villages, respectively. In the subsequent
cross-sectional surveys conducted each year, the preva-
lence of P. falciparum decreased steadily in both villages
as shown Figures 1 and 2. The risk of P. falciparum
infection was higher in residents of lowland village, OR
= 12.28 (95%CI: 9.44 - 15.10, p < 0.001) compared to
highland village. The risk of infection decreased by year,
with an OR of 0.564 (95% CI: 0.526-0.605, p < 0.001)
and 0.660 (95% CI: 0.602-0.730, p < 0.001), per year
compared with the baseline, for lowland and highland
villages, respectively. The decline in the point prevalence
o fp a r a s i t e a m i aw a ss e e ni na l la g eg r o u p si nb o t hv i l -
lages (Figure 3), but was most pronounced among one
Table 1 Number of participants surveyed per village per year
Village Age group (years) Number of participants surveyed per year
2003 2004 2005 2006 2007 2008
Lowland village <1 30 15 20 30 23 5
1 35 48 55 34 35 21
2 31 63 61 52 14 20
3 29 45 79 52 20 7
4 26 47 63 70 23 20
5-9 76 157 191 212 130 59
10-14 47 65 153 56 165 49
15-19 36 52 55 18 58 22
Total 310 492 677 524 468 203
Highland village <1 25 23 42 33 34 5
1 25 51 80 50 44 14
2 20 53 73 72 40 17
3 29 32 77 47 60 15
4 28 56 58 67 48 20
5-9 81 160 123 220 207 55
10-14 44 63 75 90 141 52
15-19 31 54 46 28 40 34
Total 283 492 574 607 614 212
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lage (lowland village). During the study, reported use of
both impregnated nets and/or non-impregnated bed net
increased from 32% to about 80% in the high transmis-
sion village (lowland village) and from 4% to about 60%
in the low transmission village (highland village).
Use of a bed nets was associated with a reduction in the
risk of parasitaemia OR = 0.666 (95%CI: 0.575 - 0.770, p
< 0.001). When the effect of the use of bed nets was
assessed in each village separately, it was found that the
use of bed nets was not associated with a reduction in
the risk of malaria parasitaemia in highland village (OR =
0.921 (95%CI: 0.708 - 1.198, p = 0.540), but was signifi-
cant in lowland village (OR = 0.572 (95%CI: 0.479 -
0.681, p < 0.001).
Incidence of febrile malaria episodes by age
The age specific incidence of malaria episodes by village
is shown in Figure 4. Children below five years in low-
land village had a higher incidence than children in
highland village throughout. The incidence of episodes
of malaria (per 1,000 person years) among children
under five years of age declined dramatically in both vil-
lages during the 2003-2008 study period from 649.0
(95%CI:548.3 - 768.3) to 33.6 (95%CI:25.5 - 44.4), and
368.9 (95%CI:297.5 - 457.4) to 16.8 (95%CI:11.7 - 24.0)
in lowland and highland villages, respectively. The
decrease in incidence was most marked during the first
three years of the study and there was only a minor dif-
ference in incidence between 2006 and 2008. This was
the case in individuals of all ages and in both villages.
Haemoglobin concentration by year
The mean haemoglobin concentration of individuals liv-
ing in highland village was higher than that of those liv-
ing in lowland village. In highland village, mean
haemoglobin concentration was highest in 2003,
whereas in lowland village it was the lowest in this year.
Similarly, the mean haemoglobin concentration of chil-
dren aged 0-3 from lowland village was markedly lower
Figure 1 Proportion of Plasmodium falciparum parasitaemia and reported use of insecticide treated or non-treated nets obtained
during cross-sectional surveys. Filled circles connected with solid lines for the proportion of Plasmodium falciparum and filled circles with
dotted lines for proportion of reported use of insecticide treated or non-treated nets. Panel A for lowland village and Panel B for highland
village.
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2003 as a baseline. Filled and open bars are for lowland and highland villages, respectively.
Figure 3 Age-specific point prevalence of Plasmodium falciparum and 95% CI (line segments) obtained during cross-sectional surveys
between 2003 and 2008 in lowland village (panel A) and highland village (panel B). Symbol representing the year of the survey, open
circles (2003), open squares (2004), open triangles (2005), open diamond (2006), filled circles (2007) and filled triangles (2008).
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Page 5 of 9Figure 4 The incidence of febrile malaria episodes among residents of lowland village (filled circles and triangles) and highland
village (filled squares and diamonds) between 2003 and 2008. Full lines represent children < 5 years, while dashed lines are individuals
aged ≥ 5 years.
Figure 5 Age-specific mean haemoglobin concentration (g/dl) measured during cross-sectional surveys between 2003 and 2008 in
lowland (A) and highland (B) villages, respectively. Graduated grey colour shows year of survey and line segments represent 95% CI.
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for effect of age and sex, there was a trend to increasing
mean haemoglobin concentration in lowland village by
year (Table 2). Contrarily, the mean haemoglobin was
significantly lower in highland village in all surveys con-
ducted in 2004-2008 compared to one in 2003, (Table 2
and Figure 5). In lowland village, use of bed nets had no
apparent effect on mean haemoglobin concentration
while in highland village it was associated with a signifi-
cantly increase in mean haemoglobin by 0.149 g/dl. In
both villages, the presence of Plasmodium falciparum
parasitaemia was associated with a lower mean haemo-
globin concentration (Table 2).
Discussion
This community based study assessed the malaria bur-
den in two villages in Korogwe district, north-eastern
Tanzania by collecting data in repeated cross-sectional
surveys and by employing CORPS to monitor malaria
morbidity over six consecutive years. In this study, low-
land residents had almost a twelve-fold increase in the
risk of malaria parasitaemia compared to their counter-
parts in the highland village. At the start of the study,
the lowland village could be categorized as high trans-
mission whereas transmission in the highland village
could be categorized as moderate. During the six years
of the study, there was a marked and progressive decline
in the malaria burden and this was reflected in the point
prevalence of parasitaemia, the incidence of clinical epi-
sodes of malaria and in the mean haemoglobin
concentration.
It is well established that immunity to malaria is a
function of age, and that in areas of high transmission
the malaria burden mainly is carried mainly by chil-
dren and infants, while in areas of low transmission,
all age groups are affected [23]. As malaria
transmission declined in the study area, a change in
the age distribution of the malaria burden was
detected. In 2003, young children resident in the high
transmission village had a markedly higher incidence
of malaria fevers than older children and young adults,
and many of these children were anaemic. Indeed, the
most striking finding of this study was the pronounced
increase in the haemoglobin concentrations among 1-3
year old children in the lowland village. This repre-
sents a remarkable health gain and underscores find-
ings of previous studies showing the high impact
malaria has on haemoglobin levels in young children
in areas of high transmission [15,24,25]
During the study, the malaria burden also decreased
among inhabitants of highland village and among the
older age groups in lowland village, but because the
decline in burden was more pronounced among the
young children in lowland village, the net effect was
that, at the end of the study the malaria burden
appeared to be more equally distributed among the dif-
ferent age groups. During the study, many cases of
severe malaria were not documented. This is probably
due to the fact that a relatively low number of indivi-
duals were surveyed, and that these individuals had
access to prompt and effective treatment. Thus, how the
decline in transmission has affected the incidence of
severe malaria in its different manifestations could not
be estimated. This, is an important question as cerebral
malaria has been reported to affect slightly older chil-
dren than those affected by severe anaemia, and a
declining incidence might lead to an increase in this
severe form of malaria [14,26].
Other studies mainly based on data collected at health
facilities have documented that malaria transmission
seems to be falling in other parts of East Africa and in
some of these studies the decrease has been attributed
Table 2 Linear regression results showing the change in mean haemoglobin concentration (g/dL) in highland and
lowland villages by year and other variables when adjusted for age and gender
Lowland village Highland village
Variable Coefficient (95%CI) P-value Coefficient (95%CI) P-value
Intercept 9.253 (8.822 - 9.684) <0.001 11.073 (10.652 - 11.494) <0.001
Use of net 0.039 (-0.075 - 0.153) 0.495 0.149 (0.031 - 0.267) 0.013
P. falciparum
§ -0.388 (-0.506 - -0.27) <0.001 -0.471 (-0.642 - -0.300) <0.001
Survey period
# -0.28 (-0.400 - -0.160) <0.001 -0.254 (-0.374 - -0.134) <0.001
Year 2003 Reference
Year 2004 0.145 (-0.065 - 0.355) 0.175 -0.933 (-1.154 - -0.712) <0.001
Year 2005 0.327 (0.129 - 0.525) 0.001 -1.199 (-1.42 - -0.978) <0.001
Year 2006 0.286 (0.076 - 0.496) 0.008 -1.248 (-1.469 - -1.027) <0.001
Year 2007 0.134 (-0.087 - 0.355) 0.235 -1.048 (-1.269 - -0.827) <0.001
Year 2008 0.424 (0.130 - 0.718) 0.005 -0.515 (-0.821 - -0.209) <0.001
§ Blood slide positivity for Plasmodium falciparum at sampling
# Effect of blood sample collected in November versus May
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based study, a dramatic decrease in malaria indices in
the absence of specific interventions other than giving
villagers access to treatment through trained village
helpers is documented. During the first four years of the
study period, the first-line anti-malarial was SP, but
from January 2007 an ACT was used. Thus, the most
dramatic decrease in malaria burden took place when
SP, a drug to which there is widespread resistance in
the area, was in use [27]. Although the presumptive
treatment of febrile cases could have played a role in
reducing transmission[28], this could not explain the
findings. In 2005, World Vision deployed many nets in
Korogwe, including the study villages. Although the cov-
erage was not complete, there has been a substantial
increase in use of nets in the study villages, approaching
60%. It has been argued that communal effect of protec-
tion is achieved when coverage reaches 64%, which is
almost the case in these villages [26], but again whether
nets at the coverage reached could have had such pro-
nounced effects on transmission as indicated by the
decrease in point prevalence from 2003 to 2008 is still
debatable. As in Tanzania in general, there has been a
steady socio-economic development in the area, but
there have not been major changes or investments in
infrastructure in the two study villages that can explain
the decrease in malaria morbidity.
T h e r ei sn os i m p l ee x p l a n a t i o nf o rt h ed e c l i n ei n
malaria in the study villages, and it is rather an unsatis-
factory situation of having to assign this to a combina-
tion of different factors such as climatic changes, better
health provision, increased coverage of bed nets and
socio economical development. It is very important to
establish the relative contribution of these and other fac-
tors to the decline in malaria, as this will shed light on
the risk that malaria might strike back. Entomological
studies in the study villages were not done during the
study period and whether there have been changes in
mosquitoes distribution across years is not established.
In conclusion, there has been a dramatic progressive
decline in point prevalence of malaria in the study vil-
lages during the study period, and in parallel the malaria
disease burden has fallen, especially among those most
affected previously, the infants and young children living
in the village where malaria transmission was high
previously.
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